1036 Treg-specific TCR signaling as a target of cancer immunotherapy

1036 Treg-specific TCR signaling as a target of cancer immunotherapy

Bibliographic Details
Main Authors:	Atsushi Tanaka, Shimon Sakaguchi, Yamin Qian
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy
by: Christopher Tay, et al.
Published: (2020-12-01)

Beyond TCR Signaling: Emerging Functions of Lck in Cancer and Immunotherapy
by: Ursula Bommhardt, et al.
Published: (2019-07-01)

Multiple Treg suppressive modules and their adaptability
by: James Badger Wing, et al.
Published: (2012-06-01)

TCR-like antibodies in cancer immunotherapy
by: Qinghua He, et al.
Published: (2019-09-01)

P1036: VOLUMETRIC SPLENOMEGALY IN PATIENTS WITH POLYCYTHEMIA VERA
by: M.-W. Lee, et al.
Published: (2022-06-01)

Negative intracellular regulators of T-cell receptor (TCR) signaling as potential antitumor immunotherapy targets
by: Pierre-Louis Bernard, et al.
Published: (2023-05-01)

Single-Cell Sequencing Reveals the Transcriptome and TCR Characteristics of pTregs and in vitro Expanded iTregs
by: Zhenzhen Hui, et al.
Published: (2021-03-01)

Modulation of TCR Signaling by Tyrosine Phosphatases: From Autoimmunity to Immunotherapy
by: Patricia Castro-Sanchez, et al.
Published: (2020-12-01)

An Etio-Epidemiological Analysis of 1036 cases of cleft Lip and Palate
by: M. Sheik Alauddin, et al.
Published: (1978-12-01)

Lucrecio: sueños y realidad (DRN, IV, 757-1036)
by: Antonio Ruiz Castellanos
Published: (2021-09-01)

TCR-T Immunotherapy: The Challenges and Solutions
by: Yating Liu, et al.
Published: (2022-01-01)

Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia
by: Weijun Zhou, et al.
Published: (2022-11-01)

Leveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy
by: Hsin-Yu Liu, et al.
Published: (2021-09-01)

Decreased Treg Cell and TCR Expansion Are Involved in Long-Lasting Graves’ Disease
by: Ziyi Chen, et al.
Published: (2021-04-01)

Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
by: Zhi Pang, et al.
Published: (2023-12-01)

Rap1 prevents colitogenic Th17 cell expansion and facilitates Treg cell differentiation and distal TCR signaling
by: Sayaka Ishihara, et al.
Published: (2022-03-01)

A genetic method specifically delineates Th1-type Treg cells and their roles in tumor immunity
by: Masaaki Okamoto, et al.
Published: (2023-07-01)

The Promise of Personalized TCR-Based Cellular Immunotherapy for Cancer Patients
by: Marion Arnaud, et al.
Published: (2021-07-01)

TCR-NK Cells: A Novel Source for Adoptive Immunotherapy of Cancer
by: Zeynep Sena Karahan, et al.
Published: (2023-03-01)

Higher Sensitivity of Foxp3+ Treg Compared to Foxp3- Conventional T Cells to TCR-Independent Signals for CD69 Induction.
by: Anna Bremser, et al.
Published: (2015-01-01)

Why Treg should be the focus of cancer immunotherapy: The latest thought
by: Ziyu Liu, et al.
Published: (2023-12-01)

TCR engineered T cells for solid tumor immunotherapy
by: Yikai Zhang, et al.
Published: (2022-06-01)

Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas
by: Amoozgar, Zohreh, et al.
Published: (2022)

Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas
by: Zohreh Amoozgar, et al.
Published: (2021-05-01)

Plinius‘ Otium-Vorstellung: Ein Vorbild für uns? (Plin. epist. 10,36)
by: Larah Krause
Published: (2023-12-01)

On the Interpretation of John Scylitzes’ Evidence About Archontes of Rhos, AM 6544 (1036 AD)
by: Alexandr A. Romensky
Published: (2020-12-01)

Validation and promise of a TCR mimic antibody for cancer immunotherapy of hepatocellular carcinoma
by: Chang Liu, et al.
Published: (2022-07-01)

Targeting KRASG12V mutations with HLA class II-restricted TCR for the immunotherapy in solid tumors
by: Qi Ai, et al.
Published: (2023-05-01)

Treg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trials.
by: James F Curtin, et al.
Published: (2008-04-01)

Rapid Generation of TCR and CD8αβ Transgenic Virus Specific T Cells for Immunotherapy of Leukemia
by: Gagan Bajwa, et al.
Published: (2022-04-01)

TCR Coexpression Signature Predicts Immunotherapy Resistance in NSCLC
by: Yuntao Wang, et al.
Published: (2022-05-01)

Exosome-Modified Liposomes Targeted Delivery of Thalidomide to Regulate Treg Cells for Antitumor Immunotherapy
by: Yang Yang, et al.
Published: (2023-03-01)

Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis
by: Eric T Clambey, et al.
Published: (2021-04-01)

The potential applications of T cell receptor (TCR)-like antibody in cervical cancer immunotherapy
by: Sylvia Annabel Dass, et al.
Published: (2021-09-01)

P1036: REAL-WORLD EFFICACY AND SAFETY OF MIDOSTAURIN-TREATMENT IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS
by: Johannes Lübke, et al.
Published: (2023-08-01)

Organisation of, and ligand-independent signalling by the TCR, with a special emphasis on the pre-TCR
by: Huang, E
Published: (2017)

Promises and Pitfalls of Next-Generation Treg Adoptive Immunotherapy
by: Panayiota Christofi, et al.
Published: (2023-12-01)

Targeting ubiquitin signaling for cancer immunotherapy
by: Xiaofei Zhou, et al.
Published: (2021-01-01)

Erratum: Rapid generation of TCR and CD8αβ transgenic virus specific T cells for immunotherapy of leukemia
by: Frontiers Production Office
Published: (2023-03-01)

An efficient method to identify virus-specific TCRs for TCR-T cell immunotherapy against virus-associated malignancies
by: Lei Chen, et al.
Published: (2021-09-01)